| Nov 7 |
Agios Pharmaceuticals (NASDAQ:AGIO) Is Posting Healthy Earnings, But It Is Not All Good News
|
| Nov 5 |
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
|
| Nov 1 |
Deep Dive Into Alnylam Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
|
| Nov 1 |
AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down
|
| Nov 1 |
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?
|
| Nov 1 |
Agios Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Nov 1 |
Agios Pharmaceuticals Inc (AGIO) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
|
| Oct 31 |
Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript
|
| Oct 31 |
Agios Pharmaceuticals (AGIO) Misses Q3 Earnings and Revenue Estimates
|
| Oct 31 |
Agios Pharmaceuticals GAAP EPS of $16.22 beats by $7.53, revenue of $8.96M misses by $0.54M
|
